HP
MTACU

Hartree Partners’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Hartree Partners’s Portfolio MTACU Stock Details MTACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,730,000
Closed -$17.3M – 185
2021
Q2 		$17.3M Buy
1,730,000
+86,200
+5% +$872K 4.04% 3
2021
Q1 		$16.5M Buy
1,643,800
+263,800
+19% +$2.81M 2.85% 3
2020
Q4 		$14.5M Buy
+1,380,000
New +$14.4M 3.29% 9

Other funds holding MTACU

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Hartree Partners's MTACU Position: Q3 2021 in Review

Hartree Partners sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2021, closing a stake of 1,730,000 shares — an estimated $17.3M sold.

Hartree Partners first reported a position in MTACU in Q4 2020 and held it in 3 quarters. The position peaked at $17.3M in Q2 2021. 20 funds tracked by Wall St. Rank hold MTACU as of Q3 2021.

  • Hartree Partners reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2021 after selling out during the quarter.
  • Hartree Partners sold 1,730,000 MedTech Acquisition Corporation Unit shares in Q3 2021, an estimated $17.3M.
  • Hartree Partners first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 3 quarters.
  • Hartree Partners's MedTech Acquisition Corporation Unit position peaked at $17.3M in Q2 2021.
  • 20 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2021.

Based on Hartree Partners's 13F filing for Q3 2021, filed 16 Nov 2021.